Patents by Inventor Aliki Stathopoulou

Aliki Stathopoulou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for determination of CK19 expression
    Patent number: 9593374
    Abstract: Disclosed is a method for quantitative determination of CK-19 mRNA positive cells in a biological sample. The method can be used, for instance, with peripheral blood to detect cancer in a patient. In one embodiment, the method can be used to detect the cancer before initiation of adjuvant treatment, thereby providing information about therapeutic efficacy. Practice of the invention method is sensitive, reliable, and easy to perform.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: March 14, 2017
    Inventors: Lianidou Evriklia, Aliki Stathopoulou, Dimitrios Mavroudis, Vasileios Georgoulias
  • Composition and method for determination of ck19 expression
    Publication number: 20140057265
    Abstract: Disclosed is a method for quantitative determination of CK-19 mRNA positive cells in a biological sample. The method can be used, for instance, with peripheral blood to detect cancer in a patient. In one embodiment, the method can be used to detect the cancer before initiation of adjuvant treatment, thereby providing information about therapeutic efficacy. Practice of the invention method is sensitive, reliable, and easy to perform.
    Type: Application
    Filed: September 19, 2013
    Publication date: February 27, 2014
    Applicant: DX4U GMBH
    Inventors: Lianidou Evriklia, Aliki Stathopoulou, Dimitrios Mavroudis, Vasileios Georgoulias
  • Composition and method for determination of ck19 expression
    Publication number: 20100015604
    Abstract: Disclosed is a method for quantitative determination of CK-19 mRNA positive cells in a biological sample. The method can be used, for instance, with peripheral blood to detect cancer in a patient. In one embodiment, the method can be used to detect the cancer before initiation of adjuvant treatment, thereby providing information about therapeutic efficacy. Practice of the invention method is sensitive, reliable, and easy to perform.
    Type: Application
    Filed: August 16, 2006
    Publication date: January 21, 2010
    Inventors: Evriklia Lianidou, Aliki Stathopoulou, Dimitrios Mavroudis, Vasileios Georgoulias